Women who received HPV Vaccine May Need Another Shot

1 Response

  1. redpill says:

    There are over 100 strains of HPV, only about 15 of which can “contribute” to cervical.There are many other co-factors just like with other forms of cancer. One brand of gardasil has 4 strains, one has 9 strains of VLP. The 9 stains version surpasses the FDA recommended allowance of aluminum that can be given to a person.

    -The incubation period for HPV averages 20 years with the median age of sufferers being 48. Which means no one can confirm if the vaccine works for at least 15 years. Some reports state 20. Merck/CDC stated in December2012 during the Katie Couric show via their Rep that the vaccines
    duration is 2-4 years. There is to date no scientific data to confirm that because cervical cancer takes 15-20 years to develop in the average woman. See the contradiction here. So if a child begins the jabs at 9-does she get one every 2 years or 4 for the next 15 years? That means she would have accumulated in her body 225 mcg of aluminum (as amorphous aluminum hydroxyphosphate sulfate adjuvant) per dose 675 mcg for the first 3 shot round. Multiple that by
    16 doses at 675 per 3 shot round if the young lady is re-vaccinated every two years as recommended by the CDC. That would mean she has accumulated 3600 mcg of aluminum. Every 4 years because the CDC has posted contradictory information that would be 2015 mcg aluminum.
    Look at this short video on the affects Aluminum has on the body:
    The Effect of Aluminum in Vaccines on Humans: https://www.youtube(dot)com/watch?v=yCzdliixnmI

    -The finding of HPV viral DNA integrated in most cellular genomes of cervical carcinomas supports epidemiologic data linking this agent to cervical cancer however, direct causation has not been demonstrated.
    Cervical Cancer Prevention, Health Professional Version, National Cancer Institute (NCI)
    http://www(dot)cancer.gov/cancertopics/pdq/prevention/cervical/healthprofessional/allpages

    -While there are well-established cancer registries in the United States, it will take decades before the impact of vaccine on cervical cancer is observed. More proximal measures of vaccine impact include outcomes such as prevalence of HPV vaccine types, incidence of cervical pre-cancers and genital warts.
    Post-licensure monitoring of HPV vaccine in the United States, Centers for Disease Control and Prevention,Vaccine.2010 Jul 5;28 (30):4731-7. Epub 2010 Feb 25,
    http://www(dot)ncbi.nlm.nih.gov/pubmed/20188681

Leave a Reply

Your email address will not be published. Required fields are marked *